-+ 0.00%
-+ 0.00%
-+ 0.00%

Pulmonx Q2 FY26 net loss narrows 34% to $10.1 million; revenue drops 5% to $22.8 million

PUBT·07/29/2026 20:15:47
Listen to the news
Pulmonx Q2 FY26 net loss narrows 34% to $10.1 million; revenue drops 5% to $22.8 million
  • Pulmonx Q2 2026 revenue fell 5% from a year earlier to USD 22.8 million, with U.S. revenue down 4% to USD 14.2 million.
  • International revenue dropped 6% to USD 8.6 million, attributed to no sales into China while awaiting renewal of a registration certificate.
  • GAAP net loss narrowed to USD 10.1 million, or USD 0.24 per share, from USD 15.2 million, or USD 0.38 per share.
  • Gross margin expanded 6 percentage points to a record 78%, while operating expenses decreased 16% to USD 26.8 million.
  • Full-year revenue outlook maintained at USD 90 million to USD 92 million; gross margin view raised to about 76%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulmonx Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607291605PRIMZONEFULLFEED9800348) on July 29, 2026, and is solely responsible for the information contained therein.